Evidence map›Paper›PMID 32561333›Full record

Observational studyNeurologia

Impact of the COVID-19 pandemic on headache management in Spain: an analysis of the current situation and future perspectives.

A López-Bravo, D García-Azorín, R Belvís, C González-Oria, G Latorre, S Santos-Lasaosa, Á L Guerrero-Peral

Abstract readMulticenter StudyObservational Study
In one paragraph

Observational study in Neurologia. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Post-COVID Headache: A Literature Review.Current pain and headache reports · 2022
    Review
  5. Article
  6. Article
  7. Observational
  8. Observational
  9. Article
  10. Article
  11. Article
  12. Article
  13. Observational
  14. Article
  15. Observational
  16. Article
  17. Article
  18. Observational
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

A López-BravoServicio de Neurología-Unidad de Tratamiento del Dolor, Hospital Reina Sofía, Navarra, España; Instituto de Investigación Sanitaria Aragón (IIS-A).
D García-AzorínUnidad de Cefaleas, Servicio de Neurología, Hospital Clínico Universitario de Valladolid, Valladolid, España. Electronic address: davilink@hotmail.com.
R BelvísUnidad de Cefaleas, Servicio de Neurología, Hospital de la Santa Creu i Sant Pau, Barcelona, España.
C González-OriaUnidad de Cefaleas, Hospital Virgen del Rocío, Sevilla, España.
G LatorreUnidad de Cefaleas, Servicio de Neurología, Hospital Universitario de Fuenlabrada, Fuenlabrada, España; Departamento de Medicina, Universidad Rey Juan Carlos, Madrid, España.
S Santos-LasaosaInstituto de Investigación Sanitaria Aragón (IIS-A); Unidad de Cefaleas, Servicio de Neurología, Hospital Clínico Universitario Lozano Blesa, Zaragoza, España.
Á L Guerrero-PeralUnidad de Cefaleas, Servicio de Neurología, Hospital Clínico Universitario de Valladolid, Valladolid, España; Instituto de Investigación de Salamanca (IBSAL), Salamanca, España; Departamento de Medicina, Universidad de Valladolid, Valladolid, España.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThe COVID-19 pandemic has had a great impact on healthcare systems. Spain, where headache is the main reason for outpatient neurology consultation, is one of the countries with the most reported cases of the disease.

objectiveThis study aimed to analyse the impact of the COVID-19 pandemic on headache units in Spain and to evaluate how neurologists see the future of these units.

methodsWe conducted a cross-sectional online survey of headache units during the sixth week of the state of alarm declared in Spain in response to the pandemic.

resultsThe response rate was 74%, with the participation of centres with different characteristics and from all Autonomous Communities of Spain. Limitations in face-to-face activity were reported by 95.8% of centres, with preferential face-to-face consultation being maintained in 60.4%, and urgent procedures in 45.8%. In 91.7% of centres, the cancelled face-to-face activity was replaced by telephone consultation. 95.8% of respondents stated that they would use personal protection equipment in the future, and 86% intended to increase the use of telemedicine. The majority foresaw an increase in waiting lists (93.8% for initial consultations, 89.6% for follow-up, and 89.4% for procedures) and a worse clinical situation for patients, but only 15% believed that their healthcare structures would be negatively affected in the future.

conclusionsAs a consequence of the pandemic, headache care and research activity has reduced considerably. This demonstrates the need for an increase in the availability of telemedicine in our centres in the near future.

Indexed as

BetacoronavirusCoronavirus InfectionsPandemicsPneumonia, ViralAnalgesicsAntibodies, MonoclonalCalcitonin Gene-Related Peptide Receptor AntagonistsCOVID-19Cross-Sectional StudiesDisease ManagementEmergency Medical ServicesForecastingHeadacheHealth Care SurveysHumansOffice VisitsAnalgesicsAntibodies, MonoclonalCalcitonin Gene-Related Peptide Receptor AntagonistsAsistencia sanitariaCefaleaCOVID-19HeadacheHealthcarePandemiaPandemicTelemedicinaTelemedicine

Identifiers

PMID32561333
PMCPMC7241344

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.